ADC Therapeutics SA (ADCT) stock news · rev $81.4M
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
This ADCT news page leads with what ADC Therapeutics SA filed — not a scraped headline mill.
No cached 8-K sentence for ADCT yet. We will not pad this page with generic market recap.
Latest reported ADCT revenue for 2025-12-31 was $81.4M. Net income was -$142.6M. Revenue was up 14.9% from 2024-12-31 to 2025-12-31. ADCT currently screens at market cap $141.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ADCT stock page; for the tape open the quote page.
ADCT stock news FAQ
What are ADCT's latest revenue and net income?
Latest cached ADC Therapeutics SA (ADCT) revenue for Dec 31, 2025 was $81.4M. Net income was -$142.6M. Statements: https://lician.com/financials/adct
How did ADCT revenue change from the prior cached period?
Cached ADC Therapeutics SA (ADCT) revenue was up 14.9% from $70.8M (Dec 31, 2024) to $81.4M (Dec 31, 2025). Statements: https://lician.com/financials/adct
What is ADCT's market cap?
ADC Therapeutics SA (ADCT) market cap is $141.2M on the latest cached fundamentals snapshot.
What kind of company is ADCT?
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Where is ADCT stock news listed?
Cached stock news for ADC Therapeutics SA (ADCT) is listed at https://lician.com/news/adct. Filings: https://lician.com/sec/adct
Not investment advice.